Statera Biopharma, Inc. Finite-Lived Intangible Assets, Net
Statera Biopharma, Inc. had Finite-Lived Intangible Assets, Net of $1.24 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2022-11-14
- 2022-09-30: Finite-Lived Intangible Assets, Net $1.24M.
- 2022-06-30: Finite-Lived Intangible Assets, Net $1.35M.
- 2022-03-31: Finite-Lived Intangible Assets, Net $1.47M.
- 2021-12-31: Finite-Lived Intangible Assets, Net $1.58M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2022-09-30 | $1.24M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.35M 10-Q · filed 2022-10-28 |
| 2022-03-31 | $1.47M 10-Q · filed 2022-10-21 |
| 2021-12-31 | $1.58M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $1.58M 10-Q · filed 2021-11-15 |
| 2020-12-31 | $0.00 10-K · filed 2022-10-06 |